In this study we report that targeting MEN1 gene-encoded protein menin, known as an important DOT1L cofactor in MLL-rearranged leukaemia and antiestrogen therapy-resistant breast cancer cells [10], [7] may represent an effective therapeutic approach against OC. This evidence concerns the gene KMT2A and breast carcinoma.